JP2010539180A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539180A5
JP2010539180A5 JP2010524978A JP2010524978A JP2010539180A5 JP 2010539180 A5 JP2010539180 A5 JP 2010539180A5 JP 2010524978 A JP2010524978 A JP 2010524978A JP 2010524978 A JP2010524978 A JP 2010524978A JP 2010539180 A5 JP2010539180 A5 JP 2010539180A5
Authority
JP
Japan
Prior art keywords
pyrrolidin
ylethyl
oxo
tetrahydroisoquinolin
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010524978A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539180A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/075981 external-priority patent/WO2009036144A1/en
Publication of JP2010539180A publication Critical patent/JP2010539180A/ja
Publication of JP2010539180A5 publication Critical patent/JP2010539180A5/ja
Withdrawn legal-status Critical Current

Links

JP2010524978A 2007-09-12 2008-09-11 ヒスタミン３拮抗薬としてのイソキノリニルおよびイソインドリニル誘導体 Withdrawn JP2010539180A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99363607P 2007-09-12 2007-09-12
PCT/US2008/075981 WO2009036144A1 (en) 2007-09-12 2008-09-11 Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists

Publications (2)

Publication Number Publication Date
JP2010539180A JP2010539180A (ja) 2010-12-16
JP2010539180A5 true JP2010539180A5 (enExample) 2011-09-29

Family

ID=40261509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010524978A Withdrawn JP2010539180A (ja) 2007-09-12 2008-09-11 ヒスタミン３拮抗薬としてのイソキノリニルおよびイソインドリニル誘導体

Country Status (25)

Country Link
US (1) US20090069300A1 (enExample)
EP (1) EP2200989A1 (enExample)
JP (1) JP2010539180A (enExample)
KR (1) KR20100054856A (enExample)
CN (1) CN101848896A (enExample)
AP (1) AP2010005202A0 (enExample)
AR (1) AR068423A1 (enExample)
AU (1) AU2008298926A1 (enExample)
BR (1) BRPI0817061A2 (enExample)
CA (1) CA2699384A1 (enExample)
CL (1) CL2008002726A1 (enExample)
CO (1) CO6300955A2 (enExample)
CR (1) CR11303A (enExample)
DO (1) DOP2010000079A (enExample)
EA (1) EA201000316A1 (enExample)
EC (1) ECSP10010025A (enExample)
MA (1) MA31699B1 (enExample)
MX (1) MX2010002760A (enExample)
NI (1) NI201000036A (enExample)
PA (1) PA8795701A1 (enExample)
PE (1) PE20090651A1 (enExample)
TN (1) TN2010000105A1 (enExample)
TW (1) TW200927114A (enExample)
WO (1) WO2009036144A1 (enExample)
ZA (1) ZA201001751B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200823204A (en) * 2006-10-17 2008-06-01 Arena Pharm Inc Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
PT2464645T (pt) * 2009-07-27 2017-10-11 Gilead Sciences Inc Compostos heterocíclicos fusionados como moduladores do canal de iões
WO2012003392A1 (en) 2010-07-02 2012-01-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
EP2632461A4 (en) * 2010-10-29 2014-04-02 Merck Sharp & Dohme Isoindolinone PDE10 INHIBITORS
AU2012253653A1 (en) * 2011-05-10 2013-05-02 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
NO3175985T3 (enExample) 2011-07-01 2018-04-28
TWI622583B (zh) 2011-07-01 2018-05-01 基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
US9173395B2 (en) 2011-07-04 2015-11-03 Bayer Intellectual Property Gmbh Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
WO2013076590A1 (en) 2011-11-23 2013-05-30 Oxygen Healthcare Research Pvt. Ltd Benzothiazine compounds as h3 receptor ligands
CN105254554B (zh) * 2014-07-14 2018-01-30 南开大学 一种制备异吲哚啉酮类化合物的方法
US20230167093A1 (en) * 2020-04-08 2023-06-01 Remix Therapeutics Inc. Compounds and methods for modulating splicing
EP4203952A4 (en) 2020-08-28 2024-12-11 Kumquat Biosciences Inc. HETEROCYCLIC COMPOUNDS AND USES THEREOF
US12496297B1 (en) * 2020-10-23 2025-12-16 Washington University Compositions of autophagy modulating agents and uses thereof
CN115819347B (zh) * 2022-11-14 2024-08-30 暨明医药科技（苏州）有限公司 一种1-烷基-3-溴吡唑的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933829A (en) * 1974-08-22 1976-01-20 John Wyeth & Brother Limited 4-Aminoquinoline derivatives
US4166853A (en) * 1978-05-05 1979-09-04 The Upjohn Company Antihypertensive 7-trifluoromethyl-4-aminoquinolones
US4159331A (en) * 1978-05-05 1979-06-26 The Upjohn Company Antihypertensive 4-aminoquinolines
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
CA2287984A1 (en) * 1997-05-01 1998-11-05 Gerald Floyd Smith Antithrombotic agents
WO2002076925A2 (en) 2001-03-23 2002-10-03 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
MY140236A (en) * 2002-09-19 2009-12-31 Lilly Co Eli Diarylether compounds useful as opioid receptor antagonists
ATE381566T1 (de) * 2004-05-14 2008-01-15 Millennium Pharm Inc Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
US20060014733A1 (en) * 2004-07-19 2006-01-19 Pfizer Inc Histamine-3 agonists and antagonists
US7381732B2 (en) * 2004-10-26 2008-06-03 Bristol-Myers Squibb Company Pyrazolobenzamides and derivatives as factor Xa inhibitors
EP1848696A1 (en) * 2005-01-21 2007-10-31 Schering Corporation Imidazole and benzimidazole derivates useful as histamine h3 antagonists
JP2008537953A (ja) * 2005-04-15 2008-10-02 エラン ファーマシューティカルズ，インコーポレイテッド ブラジキニンｂ１受容体拮抗作用に有用な新規化合物

Similar Documents

Publication Publication Date Title
JP6298115B2 (ja) Ｌｒｒｋ２調節薬としてのピラゾールアミノピリミジン誘導体
US10519137B2 (en) Pyrazolyl quinoxaline kinase inhibitors
JP2022531801A5 (enExample)
RU2015122414A (ru) Соединения n-пирролидинилмочевины, n'-пиразолилмочевины, тиомочевины, гуанидина и цианогуанидина как ингибиторы киназы trka
RU2015132181A (ru) Фтор-[1,3]-оксазины в качестве ингибиторов васе1
JP2011518836A5 (enExample)
CA2567662A1 (en) Compounds and compositions as protein kinase inhibitors
JP2019525941A5 (enExample)
JP2019519484A5 (enExample)
JP2020505454A5 (enExample)
JP2013531074A5 (enExample)
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
JP2010539180A (ja) ヒスタミン３拮抗薬としてのイソキノリニルおよびイソインドリニル誘導体
KR102082331B1 (ko) Cot 조정제로서의 6-아미노-퀴놀린-3-카르보니트릴
JP2013519733A5 (enExample)
JP2011503166A5 (enExample)
JP2014517833A5 (enExample)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2015514072A5 (enExample)
JP2013510876A5 (enExample)
RU2018142987A (ru) Положительные аллостерические модуляторы мускаринового ацетилхолинового рецептора m4
JP2016532656A5 (enExample)
JP2013508403A (ja) オレキシン受容体調節因子としての二置換オクタヒドロピロロ［３，４−ｃ］ピロール
JP2014528446A5 (enExample)
JP2013515038A5 (enExample)